Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy

Detalles Bibliográficos
Autores principales: Roumiguie, Mathieu, Contreras-Sanz, Alberto, Kumar, Gunjan, Black, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Matters Arising
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355281/
https://www.ncbi.nlm.nih.gov/pubmed/34376681
http://dx.doi.org/10.1038/s41467-021-24837-8
_version_ 1783736730208174080
author Roumiguie, Mathieu
Contreras-Sanz, Alberto
Kumar, Gunjan
Black, Peter C.
author_facet Roumiguie, Mathieu
Contreras-Sanz, Alberto
Kumar, Gunjan
Black, Peter C.
author_sort Roumiguie, Mathieu
collection PubMed
description
format Online
Article
Text
id pubmed-8355281
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83552812021-08-30 Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy Roumiguie, Mathieu Contreras-Sanz, Alberto Kumar, Gunjan Black, Peter C. Nat Commun Matters Arising Nature Publishing Group UK 2021-08-10 /pmc/articles/PMC8355281/ /pubmed/34376681 http://dx.doi.org/10.1038/s41467-021-24837-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Matters Arising
Roumiguie, Mathieu
Contreras-Sanz, Alberto
Kumar, Gunjan
Black, Peter C.
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title_full Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title_fullStr Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title_full_unstemmed Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title_short Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
title_sort reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
topic Matters Arising
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355281/
https://www.ncbi.nlm.nih.gov/pubmed/34376681
http://dx.doi.org/10.1038/s41467-021-24837-8
work_keys_str_mv AT roumiguiemathieu reconcilingdifferencesinimpactofmolecularsubtypingonresponsetocisplatinbasedchemotherapy
AT contrerassanzalberto reconcilingdifferencesinimpactofmolecularsubtypingonresponsetocisplatinbasedchemotherapy
AT kumargunjan reconcilingdifferencesinimpactofmolecularsubtypingonresponsetocisplatinbasedchemotherapy
AT blackpeterc reconcilingdifferencesinimpactofmolecularsubtypingonresponsetocisplatinbasedchemotherapy

Ejemplares similares